The major challenge facing all pharmaceutical and biomedical companies engaged in regenerative medicine is how to precisely control the regenerative signal, whether this comes from a biological or chemical agent, at the site of repair.
As scientific understanding of regenerative medicine deepens it is apparent that, for example, stem cells require complex microenvironments that provide signals via surface chemistry, soluble factors, local elasticity, cell-to-cell communication and architecture. An inability to provide such an environment and to control the delivery and activity of stem cells continues to be a major inhibitory factor in the development of promising new cell therapies.
These challenges are not unique to cell therapy, all regenerative medicine therapies (whether cells or stimulatory agents) require precise temporal and spatial control. Locate’s platform technologies solve many of the precision drug and cell therapy challenges that are current impediments to the development of new and effective regenerative medicines.